Editorials

Lam Research's first quarter of fiscal 2027, the quarter ended September 27, 2026 and reported in a 10-Q filed October 22, 2026, shows the kind of operating leverage that makes a semiconductor-equipment business worth studying closely. Revenue rose 54% from the year-earlier quarter, but operating income rose about 80% and diluted EPS rose about 77%. The question for a value investor is how much of that is durable margin structure and how much is a cyclical upswing running through a fixed cost base. The filing data alone cannot answer that, but it can show where the leverage came from and what it is worth in cash.

Three points stand out. First, gross margin improved only modestly, by about 1.9 points, so the bulk of the operating gain did not come from pricing or product mix at the gross line. Second, operating expenses grew much more slowly than revenue. R&D rose about 16% to $666.4 million and SG&A about 25% to $348.7 million, so R&D fell from roughly 10.8% of revenue to 8.1%, and SG&A fell from roughly 5.2% to 4.2%. That spread is where most of the margin expansion came from. Third, the operating line moved about 80% while revenue moved 54%, which is classic fixed-cost absorption in a manufacturing business. Whether that persists depends on whether revenue holds at these levels, which the data cannot tell us.

Below the operating line, the picture is less flattering to the headline. Tagged interest income fell to $49.8 million from $63.9 million, and interest expense fell to $36.8 million from $42.5 million, so net interest was roughly neutral to slightly negative year over year. The effective tax rate, computed as tax expense over pre-tax income, rose to about 16.9% from about 15.6%. That tax increase is why net income grew about 75% against an operating income gain of about 80%. Share count helped a little: diluted shares fell about 1.1%, which is why EPS growth (about 77%) slightly exceeded net income growth (about 75%).

One reconciliation note: the tagged interest and other non-operating items do not sum exactly to reported pre-tax income. Operating income plus tagged interest income, less tagged interest expense, is about $3,296.7 million against a reported pre-tax figure of $3,312.2 million; the roughly $13 million gap is not explained by the tags in this extract, and it does not change the conclusions above.

The sequential trend is consistent. Gross margin sat in a narrow 49.6% to 50.4% band across the first three fiscal 2026 quarters, then moved to 51.8% in Q4 and 52.3% in Q1 FY27. Operating margin climbed in every quarter of the sequence, from 33.9% to 40.0%. Revenue rose about 22% sequentially from Q4 FY26 to Q1 FY27. Fiscal 2026 as a whole reported revenue of $23,232.7 million and net income of $7,265.4 million, the sum of the quarters reconciling to the annual tags. The margin improvement is not a single-quarter event; it has built over five reported quarters, though the step-up in the latest quarter is the largest.

Operating cash flow of $3,497.7 million in Q1 FY27 was about 1.27 times net income of $2,753.1 million, and derived free cash flow of about $3,240 million was about 1.18 times net income. Those are strong conversion figures for a single quarter. They are also the highest in the five-quarter series by a wide margin, and the reported quarterly data does not break out the working-capital movements that drove the jump, so the data cannot tell us how much of it is repeatable.

The fiscal 2026 full-year comparison is more sober. Operating cash flow was $5,857.7 million against $6,173.3 million in fiscal 2025, and derived free cash flow was about $4,891 million against about $5,414 million, a decline of roughly 10%. Capital returns are large relative to cash generation. In Q1 FY27 the company paid $1,025.0 million in buybacks and $325.4 million in dividends, about 42% of derived free cash flow. Fiscal 2026 buybacks were $3,851.3 million and dividends $1,270.6 million, which together exceeded derived free cash flow for the year. Share count reduction in the latest quarter was modest, consistent with buybacks largely offsetting equity compensation of $114.7 million in the quarter.

A single strong quarter cannot establish a margin regime. The fiscal 2026 data show gross margin in a narrow band for three quarters before the step-up, and the operating-margin gain is concentrated in lower R&D and SG&A intensity, which management can adjust either way. Fiscal 2026 free cash flow fell year over year even as revenue rose 26%, which is a reminder that working capital and capital spending can offset earnings in a capital-intensive equipment cycle. The reported data also contains a data-quality issue: the Q4 FY26 weighted-average share-count tags are negative (-1.69 million diluted, -1.26 million basic), which cannot be right and was not used here.

A reader should also be aware of which growth rates the platform's key-metrics panel reports. The panel's revenue growth (26.0%), net income growth (35.6%), EPS growth (38.8%) and FCF growth (-9.7%) reconcile to fiscal 2026 full-year versus fiscal 2025, not to the quarter. The quarterly comparisons in this article (54%, 75%, 77%) are the year-over-year comparisons for Q1 FY27 against Q1 FY26.

The company's own risk-factor disclosure frames the exposures that would matter most for this margin structure:

• Cyclical semiconductor demand: capital-spending swings and AI-driven demand uncertainty can compress revenue, margins and capacity utilisation at once.
• Customer and product concentration: a limited set of large customers and a few high-priced systems account for much of revenue, so a single shortfall has outsized effect.
• China exposure: about 34% of revenue is China-related, and expanded U.S. export rules and entity listings may restrict sales further.
• International exposure: about 93% of revenue is non-U.S.; tariffs, currency swings and sanctions add variability, and the tax rate depends on U.S. profitability.
• Capital returns: the company states there is no assurance that dividends and buybacks will continue, and that much of its cash is held offshore.
• Debt: $3.75 billion of senior notes and credit facilities create service obligations and covenant limits, although the quarter's interest expense was modest at $36.8 million.

The platform's computed multiples at the time of this data are shown below. They describe what the market is paying for the current earnings and cash flow stream; they do not, on their own, indicate whether that price is appropriate. The P/E and EV/EBIT figures are trailing measures, so they will move as the quarterly run rate of roughly $2.75 billion of net income enters the trailing base. A reader who believes the 40% operating margin is durable and a reader who expects margin mean-reversion toward the 34% to 35% range of earlier fiscal 2026 quarters will reach very different valuations from the same filing. The evidence here supports both framings in part, and the reader has to choose which assumption to underwrite.

Bottom line for the reader. The Q1 FY27 filing reports revenue of $8.22 billion, gross profit of $4.30 billion, operating income of $3.28 billion, net income of $2.75 billion and diluted EPS of $2.19. The most important question it raises is whether a 40% operating margin and roughly $3.2 billion of derived quarterly free cash flow are the new base or a peak in a cyclical upswing. The data here does not decide that question, and it is the question a value investor has to answer for themselves.